PROBIOTICS / MICROBIOME
(WikiLink Probiotics) - (Last Revision: 5/1/2022)
Effective gut health is a critical component of an effective age regression strategy. Because these supplements are live organisms the class of this intervention is considered a biological.
Good Bacteria
The bacteria populating the gut declines with age and the more beneficial flora gets pushed out by negative acting bacteria.
Bad Bacteria
◉ The Gut Microbiome influences virtually all health / aging processes.
◉ It dramatically retards or drives inflammation and disease processes.
◉ The microbiome includes viral, bacterial and fungal species.
◉ Altered intestinal microbiota composition in later life is associated with inflammaging, declining tissue function, and increased susceptibility to age-associated chronic diseases, including neurodegenerative dementias. [19]
Combination of Herbal Supplements and Probiotics
A team of researchers at McGill University has successfully developed a combination of herbal supplements and probiotics that can prolong the longevity of fruit flies by 60 percent and provide protection from age related chronic diseases. The technique is one of the first to successfully show a treatment that modulates the gut microbiome can result in potent lifespan-extending effects. This new study set out to examine whether a specifically designed therapeutic could modulate the make-up of a microbiome and extend an organism's lifespan. The treatment developed by the team contained three bioactive probiotics seen to be reduced in the gut microbiota of the elderly: Lactobacillus plantarum, Lactobacillus fermentum and Bifidobacteria longum. (Highlighted in formulations below) These were combined with a prebiotic herbal formulation called Triphala.
Our understanding of the human microbiome is still an emerging area of human biology and immunology. It has already been well documented that as you age, the viruses and bacterias that populate the gut change. Your microbiome is very sensitive to its environment so these changes constitute another feedback mechanism, both controlling and responding to the changing environment including your current biological age. It has also been well established that the microbiome is generating a large population of chronokines that are contributing to your BASP. As an example, one strain of bacteria produces a multifunctional hormone in your gut that has been identified as an anti-aging chronokine. That hormone is Oxytocin.
An excellent overview of the history, science and utility of Probiotics and Prebiotics can be found in this 2017 publication by the World Gastroenterology Organization. This source provides a detailed listing of the bacterial strains that positively impact specific disease process. [18]
I personally have come to realize that if you have heart-burn, indigestion, constipation or diarrhea, taking probiotics as opposed to drugs is a better, healthier and more effective long-term solution to the problem.
Providing insight into one’s health status from a gut microbiome sample is an important clinical goal in current human microbiome research. In 2020 a group published just such a tool: “A predictive index for health status using species- level gut microbiome profiling.” They introduced the Gut Micro- biome Health Index (GMHI), a biologically-interpretable mathematical formula for predicting the likelihood of disease independent of the clinical diagnosis. [14]
One study has documented the relative populations of gut microbiomes in health versus unhealthy individuals. The tabulated guide is the beginning of a guide for supplementation based on age. Source: A predictive index for health status using species- level gut microbiome profiling.[15]
There are already a large number of supplemental probiotics available on the market. There relative utility in improving health and regressing age and BASP are for the most part ambiguous as no clinical trials have been conducted on these specific combinations of bacterial supplements. Most of them are also relatively expensive. I personally don’t know the difficulties of culturing specific strains of bacteria and then packaging those live biologicals so they can be transported and administered in a beneficial therapeutic product. That said, the bread and beer industries have been doing just that, for centuries.
What fellows on this page are the highlights/abstracts from current peer reviewed publications on probiotics. Each article is linked to the full text.
Format for Dosage, Change all Below
AIR AGENT
TIME
DOSAGE
ROUTE
Oral
Oral
INTERVAL
Daily
Daily
With Food
Yes
Yes
IConcomitant / Synergistic / Additive
NOTES:
🔷 ? 🔷
The human microbiome contains over 30 trillion microorganisms per person (some estimates are up to 100 trillion), but the composition and functional characteristics of the “healthy” microbiome remain to be precisely defined. [1]
▶︎Two of the most predominant phenomena in aging include chronic low-grade inflammation (inflammaging) and changes in the gut microbiota composition (dysbiosis). Although a direct causal relationship has not been established, many studies have reported significant reductions in inflammation during aging through well-maintained gut health and microbial balance. Prebiotics and probiotics are known to support gut health and can be easily incorporated into the daily diet.
Click [√] on any of the images above to enlarge them. The images detail the connections between gut microbiome, inflammation and aging. [2021] The Potential Roles of Probiotics, Resistant Starch, and Resistant Proteins in Ameliorating Inflammation during Aging (Inflammaging) The supplemental information resources below are from the linked article above.
Component Role or Function
⫸ Christensenellaceae family
Associated with health conditions, particularly body mass index (BMI) and inflammatory bowel disease (IBD) [41,42,43,44,45]
Akkermansia muciniphila
Anti-inflammatory activities [28]
Protecting intestinal epithelial integrity [34]
Supporting colonization of SCFA-producing bacteria [35]
Bifidobacterium spp.
Producing lactate and acetate that can reduce the population of pathogenic bacteria [36]
Suppressing serum levels of pro-inflammatory cytokines [36]
Clostridium cluster
Producing butyrate [38]
Lachnospiraceae bacterium
Producing butyrate [38]
Faecalibacterium prausnitzii
Producing butyrate [27]
Strong anti-inflammatory properties [27]
Coprococcus spp.
Producing butyrate [39]
Roseburia spp.
Producing butyrate [39]
Strong anti-inflammatory properties [40]
Key:
SCFAs (overall)
Stimulating immune system [50]
Providing energy for and supporting the growth of beneficial bacteria [8]
Increasing both intestinal immunoglobulin A (IgA) and systemic immunoglobulin G (IgG) responses to prevent pathogens growth [51]
Acetate
Supporting the growth of probiotics [52]
Butyrate
Primary energy source for human colonocytes [21]
Preventing dysbiosis in epithelial cells [22]
Reducing pro-inflammatory cytokines and chemokines [23]
Propionate
Lowering lipogenesis, serum cholesterol levels, and carcinogenesis in other tissues [53]
⫷[13]
It is now understood that gut bacteria exert effects beyond the local boundaries of the gastrointestinal tract to include distant tissues and overall health. Prototype probiotic bacterium Lactobacillus reuteri has been found to upregulate hormone oxytocin and systemic immune responses to achieve a wide array of health benefits involving wound healing, mental health, metabolism, and myoskeletal maintenance. Together these display that the gut microbiome and host animal interact via immune–endocrine–brain signaling networks. Such findings provide novel therapeutic strategies to stimulate powerful homeostatic pathways and genetic programs, stemming from the coevolution of mammals and their microbiome. [[2] [3]]
• Oral treatment with a single commensal bacterial species corrects oxytocin levels and synaptic dysfunction in the VTA and selectively reverses social deficits in MHFD offspring.
• In the present study, we find that administering purified Lactobacillus reuteri organisms in drinking water induces a significant up-regulation of the neuropeptide hormone oxytocin in mice.
After three months of supplementation, A. muciniphila reduced the levels of the relevant blood markers for liver dysfunction and inflammation while the overall gut microbiome structure was unaffected. In conclusion, this proof-of-concept study (clinical trial no. NCT02637115) shows that the intervention was safe and well tolerated and that supplementation with A. muciniphila improves several metabolic parameters. [4]
Age Associated Gut Microbiota P. Value
Leuconostoc 0.025705124
Psychrobacter 0.031568982
Paracoccus 0.035230192
Pseudoalteromonas 0.036045637
Arcobacter 0.043303847
Arthrobacter 0.049887020
Microbacterium 0.051662884
Chryseobacterium 0.057383533
Enterococcus 0.003706776
Plesiomonas 0.004338397
Aliivibrio 0.010432989
Leucobacter 0.012433899
Myroides 0.015826932
Jeotgalicoccus 0.018012821
Marinilactibacillus 0.022672523
Exiguobacterium 0.023563541
Genus P. Value
This intervention in Tourquase Kill fish, prevented the decrease in microbial diversity associated with host aging and maintained a young-like gut bacterial community, characterized by overrepresentation of the key genera Exiguobacterium, Planococcus, Propionigenium and Psychrobacter. We also show that during aging the overall microbial diversity in the TK gut decreases, with increased over-representation of pathogenic Proteobacteria.
Two hub bacterial clusters were identified in Ymt fish (Materials and Method). Strikingly, one was composed of bacterial genera that were also hub-bacteria in young wild type fish (6wk) and included Exiguobacterium, Planococcus, Propionigenium and Psychrobacter (Figure 6C, Ymt network, green nodes), while the other was composed of hub bacteria from old wild-type fish (16wk) hub and included Propionibacterium, Delftia, and Citrobacter (Figure 6C and Table S6). Remarkably, the bacterial hubs identified in Omt and Abx overlapped exclusively with the old wild-type group (16wk) (Figure 6C, orange nodes, and Table S6). These results support that bacterial network topology reflects host age both in fish and mice, with younger biological age associated with larger networks. the four most abundant bacterial phyla observed in the TK are also the four most abundant phyla found in humans and mice. [11]
(6) Lactobacillus Reuter ▲ Oxytocin
Lactobacillus reuteri, Up regulates Oxytocin
Bifidobacterium longum APC1472
Improved glucose tolerance and reduced fasting cortisol levels.
The bacterial intervention reduced fasting blood glucose levels and normalized active ghrelin levels. [[12]]
🔷 ? 🔷
🔷 ? 🔷
🔷 ? 🔷
🔷 ? 🔷
Align 50 mg
Bifidobacterium longum 35624? DSM 24736/SD5220
1 billion live bacteria Single strain [[1]]
VISBIOME
Lactobacillus paracasei DSM 24733/SD5218
Lactobacillus plantarum DSM 24730/SD5209
Lactobacillus acidophilus DSM 24735/SD5212
Lactobacillus delbrueckii DSM 24734/SD5210. subspecies bulgaricus*
Bifidobacterium longum± DSM 24736/SD5220
Bifidobacterium infantis± DSM 24737/SD5219
Bifidobacterium breve DSM 24732/SD5206
Streptococcus thermophilus SM 24731/SD5207
Pro-Multi Pro Health 15 billion
Lactobacillus acidophilus (DDS-1) 4.3 Billion CFU
Lactobacillus rhamnosus (Lr-32) 4.3 Billion CFU
Bifidobacterium lactis (HN019) 1.9 Billion CFU
Lactococcus lactis (Ll-23) 1.0 Billion CFU
Bifidobacterium longum (Bl-05) 1.0 Billion CFU
Bifidobacterium bifidum/lactis (Bb-02) 1.0 Billion CFU
Lactobacillus gasserri (Lg-36) 1.0 Billion CFU
Streptococcus thermophilus (St-21) 0.5 Billion CFU
Digestive and Prebiotic Blend: 210 mg
Microbiome Plus
Lactobacillus Reuteri 3.5 billion Upregulates Oxytocin Production
Peptiva Probiotic Blend
Lactobacillus acidophilus (DDS-1) (ATCC SD6865)
Lactobacillus acidophilus (DDS-1) (ATCC SD6866)
Bifidobacterium bifidum/lactis (Bb-02) (ATCC SD6869)
Bifidobacterium ANIMALS (Bb-02) (ATCC SD6870)
Lactobacillus rhamnosus (Lr-32) (IMC501)
Lactobacillus paracesel (IMC502)
Melatonin immediate release 0.75 mg
Melatonin delayed release 0.75 mg
Gamma-Aminobutyic Acid (GABA 100 mg)
Valerian Extract (root) valereic acids 50 mg
Seed
Digestive Health / Gastrointestinal Immunity / Gut Barrier Integrity Probiotic Blend
Bifidobacterium breve SD-BR3-IT
Bifidobacterium longum SD-BB536-JP
Bifidobacterium infantis SD-M63-JP
Bifidobacterium lactis HRVD524-US (Bl-04)
Bifidobacterium breve HRVD521-US
Bifidobacterium longum HRVD90b-US
Bifidobacterium lactis SD150-BE
Bifidobacterium longum SD-CECT7347-SP
Lactiplantibacillus plantarum SD-LP1-IT
Limosilactobacillus reuteri RD830-FR
Limosilactobacillus fermentum SD-LF8-IT
Lacticaseibacillus rhamnosus HRVD113-US
Lacticaseibacillus casei HRVD300-US
Lacticaseibacillus rhamnosus SD-GG-BE
Lacticaseibacillus rhamnosus SD-LR6-IT
Ligilactobacillus salivarius SD-LS1-IT
Lacticaseibacillus casei HRVD300-US
Dermatological Health Probiotic Blend
Bifidobacterium breve SD-BR3-IT
Bifidobacterium longum SD-CECT7347-SP
Bifidobacterium lactis SD-CECT8145-SP
Lacticaseibacillus casei SD-CECT9104-SP
Ligilactobacillus salivarius SD-LS1-IT
Cardiovascular Health Probiotic Blend5.25 Billion AFU
Bifidobacterium lactis SD-MB2409-IT
Bifidobacterium lactis SD-BS5-IT
Lactiplantibacillus plantarum SD-LPLDL-UK
Micronutrient Synthesis Probiotic Blend8.05 Billion AFU
Bifidobacterium adolescentis SD-BA5-IT (DSM18352)
Limosilactobacillus reuteri SD-LRE2-IT*
Lactobacillus acidophilus (DDS-1) (ATCC SD6865)
PREBIOTICS
Dietary fiber and plant-based functional foods that improve gut health via their impact on the gut microbiome. [15] Prebiotics Prebiotics are compounds in food that induce the growth or activity of beneficial microorganisms such as bacteria and fungi.[16]
Triphala
Triphala is an Ayurvedic herbal formation used for centuries in traditional Indian medicine. It's made of dried components from the fruits of three plant species: Emblica officinalis, Terminalia bellirica and Terminalia chebula. Over the past two decades, several clinical studies have validated the ethnomedicinal claims of Triphala, finding it to positively modulate the growth of beneficial gut bacteria while inhibiting the growth of undesirable microbes. [5] [6] [7] [8] [9] [10]
What is a probiotic? YouTube Video by International Scientific Association for Pre and Probiotics
[1] Human Microbiome in Health and Disease: The Good, the Bad, and the Bugly
[2] Chapter Five - Microbes and Oxytocin: Benefits for Host Physiology and Behavior
[3] Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring
[4] Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
[5] A novel polyphenolic prebiotic and probiotic formulation have synergistic effects on the gut microbiota influencing Drosophila melanogaster physiology
[6] Longevity extension in Drosophila through gut-brain communication
[7] Therapeutic Uses of Triphala in Ayurvedic Medicine
[8] Immunomodulatory Activity of Triphala on Neutrophil Functions
[9] Therapeutic Potential of Triphala against Human Diseases
[10] In Vivo and In Vitro Evidence for the Antihyperuricemic, Anti-inflammatory and Antioxidant Effects of a Traditional Ayurvedic Medicine, Triphala
[11] Regulation of Life Span by the Gut Microbiota in The Short-Lived African Turquoise Killifish
[12] Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to human
[14] [2020] A predictive index for health status using species- level gut microbiome profiling
[16] [2016] The gut microbiota and host health: a new clinical frontier
[17] [2022] A Low-calorie diet alters the gut microbiome and delays immune aging
Probiotics links to look up:
Citation
Degnan FH. The US Food and Drug Administration and probiotics: regulatory categorization. Clinical Infectious Diseases. 2008;46(Suppl 2):S133–S136.
Didari T, Solki S, Mozaffari S, et al. A systematic review of the safety of probiotics. Expert Opinion on Drug Safety. 2014;13(2):227–239.
Duffy LC, Sporn S, Hibberd P, et al. Lactobacilli and Bifidobacteria. In: Coates PM, Betz JM, Blackman MR, et al., eds. Encyclopedia of Dietary Supplements. 2nd ed. New York, NY: Informa Healthcare; 2010:469–478.
Hibberd PL, Kleimola L, Fiorino AM, et al. No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly—a phase I open label study to assess safety, tolerability and cytokine responses. PloS One. 2014;9(12):e113456.
Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325–332.
Sanders ME, Akkermans LMA, Haller D, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010;1(3):164–185.
Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. American Journal of Gastroenterology. 2014;109:S2–S26.
Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews. 2013;(5):CD006095. Accessed at www.thecochranelibrary.com on April 24, 2015.
Guarner F, Khan AG, Garisch J, et al. World Gastroenterology Organisation Global Guidelines. Probiotics and Prebiotics. October 2011. Journal of Clinical Gastroenterology. 2012;46(6):468–481.
Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959–1969.
Hempel S, Newberry S, Ruelaz A, et al. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease. Evidence Report/Technology Assessment no. 200. Rockville, MD: Agency for Healthcare Research and Quality; 2011. AHRQ publication no. 11-E007.
Lactobacillus acidophilus, University of Maryland http://umm.edu/health/medical/altmed/supplement/lactobacillus-acidophilus